Ühishange vaktsiinide ostmine 2025

This compliance document sets mandatory requirements that bidders must submit an unconditional tender valid for 90 days, disclose any trade secrets (excluding price/evaluation data), and hold valid medicinal product import and sale rights; joint bidders must additionally appoint a jointly-liable authorised representative via power of attorney—failure on any of these points disqualifies the bid.

This procurement seeks suppliers of rotavirus and hexavalent vaccines for Estonia and Latvia’s national immunization programs, and bidders must submit a mandatory technical specification sheet listing exact product details (name, pack size, active ingredient, manufacturer, country of origin, dose count, shelf life, and valid marketing-authorization numbers in both countries) to be considered.

Bidders must submit a fixed, VAT-exclusive price per full rotavirus course and per single hexavalent dose (4-decimal precision) that will be multiplied by Estonia/Latvia’s forecast volumes to determine total tender value, with any discrepancy between Public Procurement Register and Standard Template IV resolved in favor of the latter—no additional qualifications or technical criteria are mentioned in this excerpt.

This is a mandatory lowest-price-wins tender for Estonia’s 2025 national immunisation programme, split into two lots—rotavirus vaccine (evaluated on per-course cost) and hexavalent vaccine (per-dose cost)—where the only qualification is the ability to supply CE-marked vaccines that meet the technical specification, so bid only if you can deliver large volumes at the market’s lowest tax-excluded price.

This is an open-procurement notice (not the full tender dossier) for Estonia’s 2025 joint purchase of rotavirus and hexavalent vaccines; it only sets out the ESPD form fields and contracting-authority details—no mandatory technical specs, qualification thresholds or award criteria are given, so bidders must wait for the full tender documents to decide whether to bid.

Estonia’s EHIF and Latvia’s NHS invite open e-tenders for a mandatory-supply 2025 framework agreement (lots 1–2) covering rotavirus and hexavalent vaccines, requiring EU/EEA marketing authorisation, compliance with the full technical specification in Annex 1, and submission via Estonia’s Public Procurement Register—bid only if you can deliver registered paediatric vaccines to both countries under the draft framework/sales contracts.